Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets.
Kovalchik KA, Ma Q, Wessling L, Saab F, Duquette JD, Kubiniok P, Hamelin DJ, Faridi P, Li C, Purcell AW, Jang A, Paramithiotis E, Tognetti M, Reiter L, Bruderer R, Lanoix J, Bonneil É, Courcelles M, Thibault P, Caron E, Sirois I. Kovalchik KA, et al. Among authors: tognetti m. Mol Cell Proteomics. 2022 Jan;21(1):100178. doi: 10.1016/j.mcpro.2021.100178. Epub 2021 Nov 17. Mol Cell Proteomics. 2022. PMID: 34798331 Free PMC article.
A sentinel protein assay for simultaneously quantifying cellular processes.
Soste M, Hrabakova R, Wanka S, Melnik A, Boersema P, Maiolica A, Wernas T, Tognetti M, von Mering C, Picotti P. Soste M, et al. Among authors: tognetti m. Nat Methods. 2014 Oct;11(10):1045-8. doi: 10.1038/nmeth.3101. Epub 2014 Sep 7. Nat Methods. 2014. PMID: 25194849
Deciphering the signaling network of breast cancer improves drug sensitivity prediction.
Tognetti M, Gabor A, Yang M, Cappelletti V, Windhager J, Rueda OM, Charmpi K, Esmaeilishirazifard E, Bruna A, de Souza N, Caldas C, Beyer A, Picotti P, Saez-Rodriguez J, Bodenmiller B. Tognetti M, et al. Cell Syst. 2021 May 19;12(5):401-418.e12. doi: 10.1016/j.cels.2021.04.002. Epub 2021 Apr 30. Cell Syst. 2021. PMID: 33932331 Free article.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Padrón LJ, Maurer DM, O'Hara MH, O'Reilly EM, Wolff RA, Wainberg ZA, Ko AH, Fisher G, Rahma O, Lyman JP, Cabanski CR, Yu JX, Pfeiffer SM, Spasic M, Xu J, Gherardini PF, Karakunnel J, Mick R, Alanio C, Byrne KT, Hollmann TJ, Moore JS, Jones DD, Tognetti M, Chen RO, Yang X, Salvador L, Wherry EJ, Dugan U, O'Donnell-Tormey J, Butterfield LH, Hubbard-Lucey VM, Ibrahim R, Fairchild J, Bucktrout S, LaVallee TM, Vonderheide RH. Padrón LJ, et al. Among authors: tognetti m. Nat Med. 2022 Jun;28(6):1167-1177. doi: 10.1038/s41591-022-01829-9. Epub 2022 Jun 3. Nat Med. 2022. PMID: 35662283 Free PMC article. Clinical Trial.
Cell-to-cell and type-to-type heterogeneity of signaling networks: insights from the crowd.
Gabor A, Tognetti M, Driessen A, Tanevski J, Guo B, Cao W, Shen H, Yu T, Chung V; Single Cell Signaling in Breast Cancer DREAM Consortium members; Bodenmiller B, Saez-Rodriguez J. Gabor A, et al. Among authors: tognetti m. Mol Syst Biol. 2021 Oct;17(10):e10402. doi: 10.15252/msb.202110402. Mol Syst Biol. 2021. PMID: 34661974 Free PMC article.
27 results